The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy

Herz

Volumn 25, Issue 3, 2000, Pages 176-180

  Dörner, Andrea ^a   Schultheiss, Heinz Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adenine nucleotide translocator; Dilated cardiomyopathy

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE;

ARTICLE; CONTROLLED STUDY; HEART DILATATION; HEART FAILURE; HEART MITOCHONDRION; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOCHONDRIAL RESPIRATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; VALVULAR HEART DISEASE;

BIOPSY; CARDIOMYOPATHY, DILATED; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; HEART SEPTUM; HEART VALVE DISEASES; HEART VENTRICLES; HUMANS; ISOENZYMES; MITOCHONDRIAL ADP, ATP TRANSLOCASES; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RNA, MESSENGER;

EID: 0342656164     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000590050004     Document Type: Article

References (13)

1. Dörner A, Olesch M, Giessen S, et al. Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat. Biochim Biophys Acta 1998;1417:16-24.
2. Dörner A, Pauschinger M, Badorff A, et al. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett 1997;414:258-62.
3. Dörner A, Schulze K, Rauch U, et al. Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem 1997;174:261-9.
4. Gawaz M, Douglas MG, Klingenberg M. Structure-function studies of adenine nucleotide transport in mitochondria. II. Biochemical analysis of distinct AAC1 and AAC2 in yeast. J Biol Chem 1990;265:14202-8.
5. Graham BH, Waymire KG, Cottrell B, et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997;16:226-34.
6. Hardy CJ, Weiss RG, Bottomley PA, et al. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
7. Klingenberg M. The ADP/ATP carrier in mitochondrial membranes. In: Martonosi AN, ed. The enzymes of biological membranes, Vol 4. New York: Plenum Press, 1985:511-53.
8. Pauschinger M, Doerner A, Kuehl U, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999; 99:889-95.
9. Schultheiss HP, Kühl U, Schauer R, et al. Antibodies against adenosine di/triphosphate carrier alter myocardial function by disturbing cellular energy metabolism. In: Schultheiss HP, ed. New concepts in viral heart disease. Berlin-Heidelberg: Springer, 1988: 243-58.
10. Schultheiss HP. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Basic Res Cardiol 1992;87:Suppl 1:311-20.
11. Schultheiss HP. Disturbance of the myocardial energy metabolism in dilated cardiomyopathy due to autoimmunological mechanisms. Circulation 1993;87:5 Suppl:IV43-8.
12. Schulze K, Witzenbichler B, Christmann C, et al. Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide transloctor. Cardiovasc Res (in press).
13. Stepien G, Torroni A, Chung AB, et al. Differential expression of adenine translocator isoforms in mammalian tissues and during muscle cell differentiation. J Biol Chem 1992;267:14592-7.